 |
Bmeye B.V.
AMC, Suite K2-245
Meibergdreef 9
1105 AZ Amsterdam
Website Bmeye
E-mail Bmeye
Promotion video Bmeye
T +31 (0)20 566 58 38
F +31 (0)20 697 64 24
Employees in Amsterdam: 14
Employees in R&D: 8
Year of foundation: 2005
|
Company Profile
BMEYE is a technology-based company that develops innovative medical devices for the continuous non-invasive monitoring of blood pressure and cardiovascular hemodynamics.
Based on decades of fundamental technology and sensor research, BMEYE is committed to provide researchers, clinicians and patients worldwide with precise, robust, easy-to-use solutions for continuous, entirely non-invasive, cardiovascular monitoring
BMEYE Nexfin®monitors are designed for patient safety first: all measurements are completely non-invasive, with continuous data, no events are missed and with using our comfortable finger sensor, no needles, catheters or injections are needed. The precision of the Nexfin® sophisticated and robust methods provides a full hemodynamic profile with real-time data posted within a minute.
Science and Technologies or Services
Easy diagnosis, effective treatment
Patient responses to diagnostic cardiovascular tests, to interventional devices like pacemakers and to pharmacological treatment with drugs are highly variable and unpredictable, and are often composed of dynamic changes in blood pressure, vascular resistance, stroke volume and cardiac output. Today, their assessment is based on ECG measurements and intermittent standard upper arm NIBP cuff data that misses most if not all of the dynamics of the response.
Integrated continuous measurement of blood pressure and cardiac output in the BMEYE Nexfin® device allows easy and accurate diagnosis and effective follow-up of treatment, and provides the opportunity for immediate feedback to the patient on the effects of therapy and treatment.
Early warning, early and effective response
Patient response to anesthetic agents, cardiovascular drugs and surgical intervention is highly variable and unpredictable, and their combination often induces significant and rapid changes in blood pressure and cardiac output. During surgery, blood pressure monitoring, with the exception of less than 12% of patients who get direct intra-arterial blood pressure monitoring, is accomplished by using a standard cuff-based NIBP monitor, providing only intermittent measurements every 3-5 minutes. Cardiac output monitoring is even absent except in less than 4% of patients who receive pulmonary artery catheter CO monitoring.
Integrated continuous measurement of blood pressure and cardiac output allows early recognition and treatment of rapid changes in hemodynamics (where cardiac output changes usually lead blood pressure changes siginicantly in time) and provides immediate feedback on the impact of interventions for optimal patient management.
Unlike invasive A-lines and PA catheters, which carry a risk of infection or other complications, the BMEYE Nexfin® devices provide an integrated non-invasive solution for continuous blood pressure and cardiac output monitoring. In the OR today, blood pressure and cardiac output are the only critical parameters that are not monitored continuously on all patients. Heart rate, respiration and oxygenation are all monitored continuously and non-invasively for patient safety. The BMEYE Nexfin® technology allows truly complete, integrated and continuous non-invasive vital signs safety monitoring in all patients.
Alliances
- AMC, Amsterdam
- Mayo Clinic, Rochester, MN, USA
Keywords
- Cardiovascular
- Hemodynamics
- Patient Monitoring
- Noninvasive
- Continuous
- Safe
- Precise
- Easy-to-use
- Blood Pressure
- Cardiac Output
]]>
